SYNSIGHT’s Post

🔬 Mark your calendars! The BMCS 4th Synthesis in Drug Discovery and Development 2024 is just around the corner. 📅 June 4-5, 2024 💻 Virtual meeting Do not miss out this virtual symposium exploring the vital role of synthesis in drug discovery and development! Registration deadline: June 3rd, 2024 🔗 https://lnkd.in/ebTH8NiX #BMCS #SDDD24 #DrugDiscovery #VirtualEvent

Kinetics in drug discovery - really useful review of how to measure kinetics efficiently in the early stages of drug discovery. Thanks Claire!

The first day of the 9th RSC-BMCS Fragment-based Drug Discovery Conference started with a lively discussion at the 'Meet the Experts' session. Featuring David Rees, Anna Hirsch, and Dan Erlanson. #Fragments24

qNMR applications arise in pharmaceutical industry. Here is an excellent example! This is the reason why we must enhance qNMR exchange. Looking forward to seeing more SMEs to share your qNMR experience!

One more year, we will be sponsoring the next meeting of the Spanish Drug Discovery Network (SDDN), that will take place in November in Valencia. This year the program will focus on three key areas: New Technologies in Drug Discovery, Precision Medicine, and Drug Discovery Success Stories. We encourage everyone to join us in this international conference has become an ideal networking forum for the community of drug discovery professionals. #drugdiscovery #passionforchemistry #organicsynthesis

I attended the <BIO KOREA 2024> event held at Coex Exhibition Center in Seoul. While the number of attendees hasn't fully recovered to pre-COVID-19 pandemic levels, qualitatively, it was impressive to see the participation of top-notch companies and partners from around the globe. I had pleasant conversations with various #CDMO companies from the United States, Europe, and Asia. Of course, I also exchanged warm greetings with Korean companies. I extend my gratitude to everyone who kindly exchanged business cards with warm greetings. Customers showed a high interest in Quascenta Pte. Ltd.'s offerings like eLogbook, eProcess Pro, and eResidue Pro, which aim to enhance the quality of processes. I believe this warm interest stems from the admirable sense of purpose among CDMO companies striving to deliver better quality to their customers. Personally, rather than solely aiming for sales achievements, I too aspire to take a deeper interest in Quascenta's mission to contribute to the pharmaceutical industry. I respect Ravi Moorthy, the leader of Quascenta, because he believes in integrating our software, knowledge, and experience to deliver more value to customers. #전자로그북 #eLogbook #DataIntegrity #PharmaDigitalization #We_Consider #Quality #Quascenta

Discover how and when to leverage the unique SAMDI approach to mass spec and ASMS during drug discovery in this free eGuide: https://okt.to/iMVPkI

Discover how and when to leverage the unique SAMDI approach to mass spec and ASMS during drug discovery in this free eGuide: https://okt.to/qVo3d2

𝗚𝗹𝗼𝗯𝗮𝗹 𝗩𝗶𝗰𝘁𝗼𝗿𝗶𝗮’𝘀 𝗕𝗜𝗢 𝗞𝗢𝗥𝗘𝗔 𝟮𝟬𝟮𝟰 𝗧𝗿𝗮𝗱𝗲 𝗠𝗶𝘀𝘀𝗶𝗼𝗻 𝗣𝗿𝗼𝗴𝗿𝗮𝗺 The ADKL Labs team is excited to be attending Global Victoria’s BIO KOREA 2024 Trade Mission Program. Over the last 20 years the pharmaceutical and biotech industries in Korea continue to expand and breakneck pace. As a contract research organization from Melbourne, Victoria, our business is exceptionally placed to offer unique partnerships in the growing Korean biotech market. Since being founded in 2019, ADKL Labs rapidly established a unique footing in Australia as a leading provider of contract research services. Our facility has grown extensively throughout this period, enabling us to expand our services and capabilities in synthetic, medicinal and analytical chemistry. Over this time, the team have successfully delivered multiple chemistry projects across more than 20 clients. The ADKL Labs team are rapidly becoming established as a source of trusted answers in the Australian biotech industry. Attending Global Victoria’s BIO KOREA 2024 Trade Mission Program enables the ADKL Labs team to leverage locally developed expertise across the wider biotech industry. Korea has welcomed to arrival of many preclinical drug discovery projects over recent years. Technical hurdles can often handicap the progress in such programs since highly specialized skillsets are often necessary in this field. The ADKL Labs team aims to utilize locally developed expertise and assist in the continued growth of the Korean biotech market.  #hojubio #adklontour

Our quality systems are proven and audited by biopharma manufacturers and regulatory bodies worldwide. We emphasize quality in all our processes, starting with raw material procurement through cGMP manufacturing at multiple scales, handling, and distribution. Learn more about Avantor Quality systems and regulatory compliance https://ow.ly/W2mV50RWfv4 #AvantorSetsScienceInMotion